HLS Total Assets from 2010 to 2026
| HLS Stock | CAD 4.65 0.05 1.06% |
Total Assets | First Reported 1998-12-31 | Previous Quarter 149.1 M | Current Value 140.2 M | Quarterly Volatility 110.7 M |
Check HLS Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HLS Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.2 M, Interest Expense of 12.2 M or Total Revenue of 55.7 M, as well as many indicators such as Price To Sales Ratio of 1.19, Dividend Yield of 0.0102 or PTB Ratio of 0.73. HLS financial statements analysis is a perfect complement when working with HLS Therapeutics Valuation or Volatility modules.
HLS | Total Assets |
Latest HLS Therapeutics' Total Assets Growth Pattern
Below is the plot of the Total Assets of HLS Therapeutics over the last few years. Total assets refers to the total amount of HLS Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in HLS Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. HLS Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HLS Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 159.9 M | 10 Years Trend |
|
Total Assets |
| Timeline |
HLS Total Assets Regression Statistics
| Arithmetic Mean | 163,668,101 | |
| Geometric Mean | 110,097,936 | |
| Coefficient Of Variation | 75.61 | |
| Mean Deviation | 107,742,329 | |
| Median | 159,904,000 | |
| Standard Deviation | 123,746,549 | |
| Sample Variance | 15313.2T | |
| Range | 366.2M | |
| R-Value | 0.51 | |
| Mean Square Error | 12008.8T | |
| R-Squared | 0.26 | |
| Significance | 0.03 | |
| Slope | 12,610,264 | |
| Total Sum of Squares | 245011.3T |
HLS Total Assets History
About HLS Therapeutics Financial Statements
HLS Therapeutics investors utilize fundamental indicators, such as Total Assets, to predict how HLS Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 183.9 M | 116.1 M | |
| Intangibles To Total Assets | 0.69 | 0.65 |
Other Information on Investing in HLS Stock
HLS Therapeutics financial ratios help investors to determine whether HLS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.